Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
The resilience of high-grade gliomas (HGGs) against conventional chemotherapies is due to their heterogeneous genetic landscape, adaptive phenotypic changes, and immune escape mechanisms. Innovative immunotherapies have been developed to counteract the immunosuppressive capability of gliomas. Nevert...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003180/ https://www.ncbi.nlm.nih.gov/pubmed/33803885 http://dx.doi.org/10.3390/brainsci11030386 |